scholarly journals Erlotinib as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Phase Iiib Study

2015 ◽  
Vol 26 ◽  
pp. i29
Author(s):  
B. Zaric ◽  
B. Perin ◽  
M. Cekic ◽  
M. Rancic ◽  
V. Kovcin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Egfr Mutation ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Phase Iiib ◽  
First Line Treatment

A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer

2020 ◽  
Vol 20 (6) ◽  
pp. 575-582 ◽  
Author(s):  
Susana Torres ◽  
Álvaro González ◽  
Alberto Jacobo Cunquero Tomas ◽  
Silvia Calabuig Fariñas ◽  
Macarena Ferrero ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Egfr Mutation ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Companion Diagnostic ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document